T. Matthes

Type de document

Articles (7) Recensions (2)

Co-auteur

Date

Source

Mot-clé

survie (5) Survival (5) Expression (5) Mice (4) Human beings (4) Blood (4) Development (3) Treatment (3) Tumor necrosis factor (3) Patients (3) Neutrophils (3) Bone marrow (3) Cells (3) Addition (3) Patients (3) tissu (corporel) (2) thérapie (2) protéine (2) in situ (2) analyse (2) cancer (2) Diagnosis (2) Cancer (2) Therapeutics (2) Thalidomide (2) Swiss (2) Proteoglycans (2) Multiple myeloma (2) Messenger RNA (2) Macrophages (2)

Documents écrit par T. Matthes (7) | parle de T. Matthes (0)

Targeting OLFML3 in Colorectal Cancer Suppresses Tumor Growth and Angiogenesis, and Increases the Efficacy of Anti-PD1 Based Immunotherapy.
J. Stalin et al. (15 sept. 2021)
CXCL-8/IL8 Produced by Diffuse Large B-cell Lymphomas Recruits Neutrophils Expressing a Proliferation-Inducing Ligand APRIL.
B. Manfroi et al. (1 mars 2017)
Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland
P. Samaras et al. (2015)
Using digital RNA counting and flow cytometry to compare mRNA with protein expression in acute leukemias.
P. Fernandez et al. (2012)
Integrating novel agents into multiple myeloma treatment - current status in Switzerland and treatment recommendations.
C. Taverna et al. (2010)
APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa.
B. Huard et al. (2008)
Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness.
J. Schwaller et al. (2007)